drugset

drugset / Trial / NCT01596517

Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C

NCT01596517 ↗

Phase 4 Completed 272 enrolled Asan Medical Center Gangnam Severance Hospital · collab Korea University Guro Hospital · collab Samsung Medical Center · collab Seoul St. Mary's Hospital · collab Severance Hospital · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy and effectiveness of peginterferon alfa-2a and ribavirin therapy in Korean chronic hepatitis C patients.

Timeline

Start: 2003-06
Primary completion: 2011-12
Completion: 2012-05

Publications

Heo NY, Lim YS, Lee HC, Lee YS, Kim KM, Byun KS, Han KH, Lee KS, Paik SW, Yoon SK, Suh DJ. High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice. Clin Mol Hepatol. 2013 Mar;19(1):60-9. doi: 10.3350/cmh.2013.19.1.60. Epub 2013 Mar 25.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Peginterferon alfa-2a	Protein / enzyme biologic	180 ug	—
Subject	Ribavirin	Small molecule	800 mg	—
Subject	Ribavirin	Small molecule	1000 mg	—
Subject	Ribavirin	Small molecule	1200 mg	—

Indications